Close Menu

The Fun of Reviewing

Keith Robison is more than happy to take on more manuscript reviews — though he adds that he wouldn’t want to do it full-time — and he discusses some of his experiences with reviewing. He writes that he enjoys is but occasionally isn’t satisfied with his reviews, particularly when he can’t quite figure out why he is “uneasy” with a paper and when he looks at a really good paper. “If the paper is truly good, you really don’t have much to do,” he says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.